Silence Therapeutics Plc American Depository Share Quarterly Balance Sheet
NASDAQ: SLNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Silence Therapeutics Plc American Depository Share financial position
As of Jun 30, 2026, Silence Therapeutics Plc American Depository Share reported total assets of $106.4 million, down 35.6% from a year earlier against total liabilities of $67.9 million. Shareholders' equity stood at $38.5 million, or 36.2% of assets. The company held $72.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 7.42, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Silence Therapeutics Plc American Depository Share balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 72.05M | 5.66M | 11.28M | 82.03M | 41.74M | 64.89M | 121.33M | — | — | — | 68.79M |
| Short-Term Investments | 0 | 64.42M | 73.84M | 20.16M | 72.42M | 71.65M | 26.00M | — | — | — | — |
| Receivables | — | 0 | 0 | 28.00K | 85.00K | 41.00K | 972.00K | — | — | — | 290.00K |
| Total Current Assets | 94.28M | 102.85M | 118.66M | 133.63M | 148.55M | 169.79M | 187.37M | — | — | — | 103.15M |
| Property, Plant & Equipment | 1.32M | 1.40M | 1.58M | 1.66M | 1.77M | 1.69M | 1.82M | — | — | — | 1.94M |
| Goodwill | 10.32M | 10.36M | 10.62M | 10.61M | 10.62M | 10.62M | 9.39M | 9.39M | — | 9.76M | 9.98M |
| Intangible Assets | — | — | 288.00K | — | — | — | 312.00K | — | — | — | — |
| Total Assets | 106.41M | 115.12M | 131.44M | 146.79M | 165.23M | 185.30M | 202.63M | — | — | — | 119.45M |
| Accounts Payable | — | — | 4.41M | — | — | — | 3.70M | — | — | — | 3.35M |
| Total Current Liabilities | 12.71M | 10.46M | 13.61M | 17.38M | 14.77M | 19.26M | 16.82M | — | — | — | 22.34M |
| Total Liabilities | 67.94M | 65.72M | 69.14M | 72.73M | 71.08M | 72.56M | 68.61M | — | — | — | 97.45M |
| Shareholders' Equity | 38.47M | 49.40M | 62.30M | 74.06M | 94.16M | 112.74M | 134.02M | 126.70M | 142.53M | 156.76M | 21.99M |
| Retained Earnings | -589.63M | -577.53M | -562.57M | -550.80M | -529.84M | -502.54M | -474.04M | — | — | — | -431.89M |
| Net Cash (Debt) | 72.05M | 70.08M | 85.11M | 102.19M | 114.16M | 136.53M | 147.33M | — | — | — | 68.79M |
| Shares Outstanding | 141.74M | 141.70M | 141.70M | 141.70M | 141.70M | 141.69M | 141.67M | — | — | — | 118.85M |
This table shows 11 quarterly periods of Silence Therapeutics Plc American Depository Share's balance sheet, from Q2 2026 back to Q4 2023, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow SLN's reporting calendar. What is a balance sheet?